Uscom Limited (UCM:ASX) Annual Reports & Investor Relations Material

Overview

Uscom Limited is a global medical device company that specializes in non-invasive cardiovascular and pulmonary products. Their flagship product, USCOM 1A, is a hemodynamic monitor that measures cardiovascular function using Doppler ultrasound. In addition to this, they offer BP+, a central blood pressure monitor, and SpiroSonic, a pulmonary function testing device that uses multi-path ultrasound technology. Uscom Limited also provides Ventitest, a digital solution for testing ventilators, and a digital home care spirometer called SpiroSonic AIR, which sends digital lung function signals through a phone app. The company operates through a network of distribution partners and serves hospitals and other medical care locations worldwide. They were previously known as Uscom Pty Limited before changing their name in 2003 and were founded in 1999. They are headquartered in Sydney, Australia.

Frequently Asked Questions

What is Uscom Limited's ticker?

Uscom Limited's ticker is UCM

What exchange is Uscom Limited traded on?

The company's shares trade on the ASX stock exchange

Where are Uscom Limited's headquarters?

They are based in Sydney, Australia

How many employees does Uscom Limited have?

There are 11-50 employees working at Uscom Limited

What is Uscom Limited's website?

It is https://www.uscom.com.au/

What type of sector is Uscom Limited?

Uscom Limited is in the Healthcare sector